Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

EW Orenstein, S Basu, NS Shah… - The Lancet infectious …, 2009 - thelancet.com
Multidrug-resistant (MDR) tuberculosis is a growing clinical and public-health concern. To
evaluate existing evidence regarding treatment regimens for MDR tuberculosis, we used a …

Tuberculosis, drug resistance, and the history of modern medicine

S Keshavjee, PE Farmer - New England Journal of Medicine, 2012 - Mass Medical Soc
Mycobacterium tuberculosis has been a major cause of human disease for centuries. This
article discusses the development of active drug therapy and the emergence and …

[BOOK][B] WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update

World Health Organization - 2022 - books.google.com
The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …

Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …

P Nahid, SE Dorman, N Alipanah… - Clinical infectious …, 2016 - academic.oup.com
Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

[BOOK][B] WHO consolidated guidelines on drug-resistant tuberculosis treatment

World Health Organization - 2019 - apps.who.int
Executive summary Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

NR Gandhi, P Nunn, K Dheda, HS Schaaf, M Zignol… - The Lancet, 2010 - thelancet.com
Although progress has been made to reduce global incidence of drug-susceptible
tuberculosis, the emergence of multidrug-resistant (MDR) and extensively drug-resistant …

[PDF][PDF] Multidrug and extensively drug-resistant TB (M

World Health Organization - 2010 - apps.who.int
Multidrug and extensively drug-resistant TB (M/XDR-TB) Page 1 Multidrug and extensively
drug-resistant TB (M/XDR-TB) 2010 GLOBAL REPORT ON SURVEILLANCE AND RESPONSE …

Cost-effectiveness of cervical-cancer screening in five develo** countries

SJ Goldie, L Gaffikin… - … England Journal of …, 2005 - Mass Medical Soc
Background Cervical-cancer screening strategies that involve the use of conventional
cytology and require multiple visits have been impractical in develo** countries. Methods …

Two hundred years of cancer research

VT DeVita Jr, SA Rosenberg - New England Journal of Medicine, 2012 - Mass Medical Soc
Two Hundred Years of Cancer Research | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

[CITATION][C] Guidelines for the programmatic management of drug resistant tuberculosis: Emergency update 2008

World Health Organization - World Health Organization, 2008